Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy.
about
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patientsA pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma.Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase II and III studies.Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.Efficacy and safety of lipegfilgrastim compared with placebo in patients with non-small cell lung cancer receiving chemotherapy: post hoc analysis of elderly versus younger patients.
P2860
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase III, randomized, double- ...... ving myelosuppressive therapy.
@ast
Phase III, randomized, double- ...... ving myelosuppressive therapy.
@en
type
label
Phase III, randomized, double- ...... ving myelosuppressive therapy.
@ast
Phase III, randomized, double- ...... ving myelosuppressive therapy.
@en
prefLabel
Phase III, randomized, double- ...... ving myelosuppressive therapy.
@ast
Phase III, randomized, double- ...... ving myelosuppressive therapy.
@en
P2093
P2860
P1433
P1476
Phase III, randomized, double- ...... iving myelosuppressive therapy
@en
P2093
Anton Buchner
Oleg A Gladkov
Peter Bias
Reiner Elsässer
Udo Müller
P2860
P2888
P356
10.1186/S40064-015-1067-7
P577
2015-07-03T00:00:00Z
P5875
P6179
1022600235